---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-026179"
form_type: "8-K"
ticker: "RNXT"
cik: "0001574094"
company_name: "RenovoRx, Inc."
filed_at: "2022-09-19T23:59:59+00:00"
generated_at: "2026-06-23T08:49:22.397936+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# RenovoRx appoints Angela Gill Nelms as COO; $400K salary, stock option grant

## Summary
- Angela Gill Nelms appointed COO effective Sept 19, 2022; previously COO at Florence Healthcare.
- Annual base salary $400,000, discretionary bonus target 35%, option to purchase 274,230 shares.
- Severance: 50% salary outside change-in-control, 100% plus full equity vesting during change-in-control period.
- Company expects Phase 3 TIGeR-PaC interim analysis in Q4 2022; Nelms to oversee operations.
- Also reimbursed up to $20,000 moving expenses.

## SEC filing metadata
- accession: 0001493152-22-026179
- form_type: 8-K
- ticker: RNXT
- cik: 0001574094
- company_name: RenovoRx, Inc.
- filed_at: 2022-09-19T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1574094/000149315222026179/0001493152-22-026179-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1574094/000149315222026179/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-026179
- JSON: https://secwatch.observer/filing/0001493152-22-026179.json
- Plain text: https://secwatch.observer/filing/0001493152-22-026179.txt

## Key facts
- Executive change
  Angela Gill Nelms was appointed as Chief Operating Officer at RenovoRx, Inc..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: The Board of Directors of RenovoRx, Inc. (the “Company”) has appointed Ms. Angela Gill Nelms, age 47, as Chief Operating Officer, effective September 19, 2022, her start date with the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1574094/000149315222026179/0001493152-22-026179-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.